Fatores associados ao óbito por covid-19 em hospital universitário do sul do Brasil: Estudo transversal

Autores/as

DOI:

https://doi.org/10.21527/2176-7114.2024.49.14706

Palabras clave:

COVID-19, Epidemiologia, Brasil, Hospitais Universitários, Mortalidade

Resumen

Este é um estudo transversal com coleta de dados retrospectiva que analisou 356 pacientes internados em hospital universitário referência em casos graves por COVID-19 no período temporal da primeira e segunda onda no Rio Grande do Sul, Brasil. A mortalidade foi o desfecho de interesse e variáveis significativas foram submetidas à regressão de Poisson. Noventa e nove (27,8%) pacientes tiveram óbito como desfecho. Baixa escolaridade, admissão em mal estado geral, desnutrição, ausência de diagnóstico prévio de COVID-19, apresentar outros sintomas que não gripais ou respiratórios e ter polifarmácia foram mais frequentes nos pacientes que morreram. Foram encontradas taxa de filtração glomerular reduzida, D-Dímero, proteína C reativa, uréia e Razão Normalizada Internacional elevadas quando da admissão hospitalar dos pacientes que morreram. Não foram encontradas diferenças nos óbitos entre os períodos da pandemia. Após análise multivariada, os fatores relacionados ao óbito, em ordem decrescente de prevalência, foram institucionalização, ventilação mecânica prolongada (>21 dias) e por até 21 dias, alta Razão Normalizada Internacional na admissão, idade acima de 65 anos, necessidade de diálise e insuficiência respiratória aguda. Os resultados auxiliam no conhecimento do comportamento da doença e fornecem subsídios para treinamento e alocação de recursos em cenários de demandas exponenciais de atendimento, como surtos e epidemias.

Citas

Saber-Ayad M, Saleh MA, Abu-Gharbieh E. The rationale for potential pharmacotherapy of COVID-19. Pharmaceuticals. 2020;13(5):1-29. doi:10.3390/ph13050096

Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology , diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020;55(January):12 p.

Brasil. Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Published 2023. Accessed June 11, 2023. https://covid.saude.gov.br/

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533-534. doi:10.1016/S1473-3099(20)30120-1

SES/RS. Painel Coronavírus RS. Published 2023. Accessed June 11, 2023. https://ti.saude.rs.gov.br/covid19/

Zeiser FA, Donida B, da Costa CA, et al. First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality. Lancet Reg Health - Am. 2021;6:100107. doi:10.1016/j.lana.2021.100107

Hatamabadi H, Sabaghian T, Sadeghi A, et al. Epidemiology of COVID-19 in Tehran, Iran: A Cohort Study of Clinical Profile, Risk Factors, and Outcomes. BioMed Res Int. 2022;2022:2350063. doi:10.1155/2022/2350063

Hallal PC, Victora CG. Overcoming Brazil’s monumental COVID-19 failure: an urgent call to action. Nat Med. 2021;27(6):933-933. doi:10.1038/s41591-021-01353-2

Baqui P, Bica I, Marra V, Ercole A, Schaar M van der. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health. 2020;8(8):e1018-e1026. doi:10.1016/S2214-109X(20)30285-0

Ferraretto EK. Nove Meses de Enfrentamento Da COVID-19: Relato de Experiência Do Hospital de Clínicas de Porto Alegre.; 2020.

Vaz, T. A., Avila, A. M., Mancuso, A. C. B., Zini, D. W., Pons, M. T., Borges, R. B. & Camey, S. A. Biobanco COVID-19. Published online 2020. dx.doi.org/10.22491/hcpa-biobanco

Yoshikawa, Gilberto, Castro, Roberto Chaves. Manual de Semiologia Médica: A Prática Do Exame Físico. Universidade do Estado do Pará; 2015.

WHO Consultation on Obesity (1999: Geneva S, Organization WH. Obesity : preventing and managing the global epidemic : report of a WHO consultation. World Health Organization; 2000. Accessed June 11, 2023. https://apps.who.int/iris/handle/10665/42330

Kellum, J. A., Lameire, N., Aspelin, P., Barsoum, R. S., Burdmann, E. A., Goldstein, S. L., Herzog, C. A., Joannidis, M., Kribben, A., Levey, A. S., MacLeod, A. M., Mehta, R. L., Murray, P. T., Naicker, S., Opal, S. M., Schaefer, F., Schetz, M.,; Uchino, S. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1. doi:10.1038/kisup.2012.1

Associação de Medicina Intensiva GS e, Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes Brasileiras de Ventilação Mecânica. 2013;39(1). Accessed June 11, 2023. http://www.jornaldepneumologia.com.br/details/3242/pt-BR

AMIB. Recomendações da Associação de Medicina Intensiva Brasileira para a abordagem do COVID-19 em medicina intensiva Abril 2020. Assoc Med Intensiva Bras. Published online 2020:1-77.

Malta M, Cardoso LO, Bastos FI, Magnanini MMF, Silva CMFP da. STROBE initiative: guidelines on reporting observational studies. Rev Saúde Pública. 2010;44:559-565. doi:10.1590/S0034-89102010000300021

Sousa EL de, Gaído SB, Sousa RA de, et al. Profile of hospital admissions and deaths due to severe acute respiratory syndrome caused by COVID-19 in Piauí, Brazil: a descriptive study, 2020-2021. Epidemiol E Serv Saude Rev Sist Unico Saude Bras. 2022;31(1):e2021836. doi:10.1590/S1679-49742022000100009

Deitos J, Lima RBH, Pereira DM, Seki KLM. Perfil epidemiológico e desfecho clínico de pacientes internados com COVID-19 em um Hospital Universitário de Campo Grande – MS. Res Soc Dev. 2022;11(4):e6111427046-e6111427046. doi:10.33448/rsd-v11i4.27046

Escosteguy CC, Eleuterio T de A, Pereira AGL, et al. COVID-19: a cross-sectional study of suspected cases admitted to a federal hospital in Rio de Janeiro, Brazil, and factors associated with hospital death. Epidemiol E Serviços Saúde. 2021;30(1). doi:10.1590/s1679-49742021000100023

Tiwari L, Gupta P, N Y, et al. Clinicodemographic profile and predictors of poor outcome in hospitalised COVID-19 patients: a single-centre, retrospective cohort study from India. BMJ Open. 2022;12(6):e056464. doi:10.1136/bmjopen-2021-056464

Ergenc Z, Ergenc H, Araç S, et al. Predictors of disease severity, clinical course, and therapeutic outcome in COVID-19 patients: our experience with 1,700 patients. Eur Rev Med Pharmacol Sci. 2022;26(21):8180-8187. doi:10.26355/eurrev_202211_30171

Jutzeler CR, Bourguignon L, Weis CV, et al. Comorbidities, Clinical Signs and Symptoms, Laboratory Findings, Imaging Features, Treatment Strategies, and Outcomes in Adult and Pediatric Patients with COVID-19: A Systematic Review and Meta-Analysis. Infectious Diseases (except HIV/AIDS); 2020. doi:10.1101/2020.05.20.20103804

Li Y, Ashcroft T, Chung A, et al. Risk factors for poor outcomes in hospitalised COVID-19 patients: A systematic review and meta-analysis. J Glob Health. 2021;11:10001. doi:10.7189/jogh.11.10001

Sansone NMS, Pereira LR, Boschiero MN, Valencise FE, Fraga AMA, Marson FAL. Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil. Int J Environ Res Public Health. 2022;19(15):8895. doi:10.3390/ijerph19158895

Silva BRO, Rodrigues WF, Abadia DGP, et al. Clinical-Epidemiology Aspect of Inpatients With Moderate or Severe COVID-19 in a Brazilian Macroregion: Disease and Countermeasures. Front Cell Infect Microbiol. 2022;12:899702. doi:10.3389/fcimb.2022.899702

Mascarello KC, Vieira ACBC, Souza ASS de, Marcarini WD, Barauna VG, Maciel ELN. COVID-19 hospitalization and death and relationship with social determinants of health and morbidities in Espírito Santo State, Brazil: a cross-sectional study. Epidemiol E Serv Saude Rev Sist Unico Saude Bras. 2021;30(3):e2020919. doi:10.1590/S1679-49742021000300004

Pereira RHM, Braga CKV, Servo LM, et al. Geographic access to COVID-19 healthcare in Brazil using a balanced float catchment area approach. Soc Sci Med 1982. 2021;273:113773. doi:10.1016/j.socscimed.2021.113773

Xavier AR, Silva JS, Almeida JPCL, Conceição JFF, Lacerda GS, Kanaan S. COVID-19: manifestações clínicas e laboratoriais na infecção pelo novo coronavírus. J Bras Patol E Med Lab. 2020;56:1-9. doi:10.5935/1676-2444.20200049

Ismail B, Nazri M, Harun A, Ali S, Omar M, Zainy Z. Predictors of polymyxin B treatment failure in Gram-negative healthcare-associated infections among critically ill patients. J Microbiol Immunol Infect. Published online 2017:1-7. doi:10.1016/j.jmii.2017.03.007

Baker J, Krishnan N, Abroms LC, Berg CJ. The Impact of Tobacco Use on COVID-19 Outcomes: A Systematic Review. J Smok Cessat. 2022;2022:5474397. doi:10.1155/2022/5474397

Gray WK, Navaratnam AV, Day J, Wendon J, Briggs TWR. COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study. Thorax. Published online November 2021:thoraxjnl-2021-218025. doi:10.1136/thoraxjnl-2021-218025

Machado CJ, Pereira CC de A, Viana B de M, et al. Estimativas de impacto da COVID-19 na mortalidade de idosos institucionalizados no Brasil. Ciênc Saúde Coletiva. 2020;25:3437-3444. doi:10.1590/1413-81232020259.14552020

Ho JS, Fernando DI, Chan MY, Sia CH. Obesity in COVID-19: A Systematic Review and Meta-analysis. Ann Acad Med Singapore. 2020;49(12):996-1008. doi:10.47102/annals-acadmedsg.2020299

Houvèssou GM, Leventhal DGP, Silva EV da. Obesity and COVID-19 in-hospital fatality in southern Brazil: impact by age and skin color. Rev Saúde Pública. 2022;56:4. doi:10.11606/s1518-8787.2022056004329

Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet Lond Engl. 2020;395(10239):1763-1770. doi:10.1016/S0140-6736(20)31189-2

Bedock D, Bel Lassen P, Mathian A, et al. Prevalence and severity of malnutrition in hospitalized COVID-19 patients. Clin Nutr Espen. 2020;40:214-219. doi:10.1016/j.clnesp.2020.09.018

Pujolar G, Oliver-Anglès A, Vargas I, Vázquez ML. Changes in Access to Health Services during the COVID-19 Pandemic: A Scoping Review. Int J Environ Res Public Health. 2022;19(3):1749. doi:10.3390/ijerph19031749

Silva VVA da. A COVID-19 enquanto questão social: classe, escolaridade e cor da pandemia no Pará. HOLOS. 2021;1:1-14. doi:10.15628/holos.2021.11519

Marcolino MS, Ziegelmann PK, Souza-Silva MVR, et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry. Int J Infect Dis. 2021;107:300-310. doi:10.1016/j.ijid.2021.01.019

Iloanusi S, Mgbere O, Essien EJ. Polypharmacy among COVID-19 patients: A systematic review. J Am Pharm Assoc. 2021;61(5):e14-e25. doi:10.1016/j.japh.2021.05.006

McKeigue PM, Kennedy S, Weir A, et al. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study. BMC Med. 2021;19(1):51. doi:10.1186/s12916-021-01907-8

Ghasemi H, Darvishi N, Salari N, Hosseinian-Far A, Akbari H, Mohammadi M. Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies. Trop Med Health. 2022;50:60. doi:10.1186/s41182-022-00456-x

Huang J, Xu Y, Wang B, et al. Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19. BMC Pulm Med. 2021;21(1):120. doi:10.1186/s12890-021-01487-6

Berger JS, Kunichoff D, Adhikari S, et al. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients with COVID-19. Arterioscler Thromb Vasc Biol. 2020;(October):2539-2547. doi:10.1161/ATVBAHA.120.314872

Ippolito M, Misseri G, Catalisano G, et al. Ventilator-Associated Pneumonia in Patients with COVID-19: A Systematic Review and Meta-Analysis. Antibiot Basel Switz. 2021;10(5):545. doi:10.3390/antibiotics10050545

Campos MR, Schramm JM de A, Emmerick ICM, Rodrigues JM, Avelar FG de, Pimentel TG. Carga de doença da COVID-19 e de suas complicações agudas e crônicas: reflexões sobre a mensuração (DALY) e perspectivas no Sistema Único de Saúde. Cad Saúde Pública. 2020;36(11):e00148920. doi:10.1590/0102-311x00148920

Publicado

2024-09-18

Cómo citar

Packeiser, P. B., & Pereira, L. R. L. (2024). Fatores associados ao óbito por covid-19 em hospital universitário do sul do Brasil: Estudo transversal. Revista Contexto &Amp; Saúde, 24(49), e14706. https://doi.org/10.21527/2176-7114.2024.49.14706

Número

Sección

Artigo Original